Balyasny Asset Management L.P.

Position in CMPX — Compass Therapeutics, Inc.

CIK 1218710 Chicago, IL

Back to CMPX Full portfolio

Position in CMPX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,919,986

-$2,635,900 QoQ

Shares Held

1,119,090

-29.8% QoQ

Ownership

0.621%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Derivatives in CMPX

reported options exposure · as of Mar 31, 2025

CallValue

CallShares

PutValue

$630,990

PutShares

332,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

All Filings in CMPX

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,919,986	1,119,090	-29.8%	Shares	Sole	2026-05-15
2025-12-31	$8,555,886	1,593,275	-43.6%	Shares	Sole	2026-02-17
2025-09-30	$9,892,267	2,826,362	+10435.1%	Shares	Sole	2025-11-14
2025-03-31	$630,990	332,100	—	Put	Sole	2025-05-15
2023-03-31	$87,727	26,828	-6.8%	Shares	Sole	2023-05-15
2022-12-31	$144,828	28,793	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.